-
A Systematic Review of Economic Modeling Challenges and Proposed Solutions for Rare Disease Technologies: An HTAi RDIG Initiative
Sep 22, 2025, 16:24 PM -
Cost-Effectiveness Modeling of CAR-T Cell Therapies in Hematologic Malignancies: Insights From NICE and CDA-AMC Appraisals
Sep 22, 2025, 16:24 PM -
Empirical Comparison of Subjective Well-Being and Health-Related Quality of Life Measures in Australian Adolescents
Sep 22, 2025, 16:24 PM -
Advancing Preference Elicitation Techniques for Rare Diseases and Limited Sample Populations
Sep 22, 2025, 16:24 PM -
The Value of the Health and Well-being Benefits of Healthcare Facilities Outdoor Spaces
Sep 22, 2025, 16:24 PM -
Seeking Patient and Public’s Opinions to Determine Target Differences in Clinical Trials: A Scoping Review of Elicitation Methods
Sep 22, 2025, 16:24 PM -
Carbon Footprint Associated With Severe Asthma Care Before and After Benralizumab Initiation: BENEFIT Study
Sep 22, 2025, 16:24 PM -
Associations Between Undernutrition and Healthcare Utilization and Costs in Community-Dwelling Adults: A Longitudinal Observational Study
Sep 22, 2025, 16:24 PM -
Incorporating Environmental Impacts Into Budget Impact Models: A Case Study of CAR-T Therapies in France
Sep 22, 2025, 16:24 PM -
"Tell Me a Story": A Randomized Study Comparing Tabulated and Narrative Presentations of a Discrete Choice Experiment
Sep 22, 2025, 16:24 PM -
Approximating Competing Risk Events From Published Kaplan-Meier Curves Using Simultaneity-Based Event Assignment Methods
Sep 22, 2025, 16:24 PM -
Do Older People Always Prefer Avoiding Nursing Homes? Evidence in France From a Mixed-Methods Approach
Sep 22, 2025, 16:24 PM -
The Healthcare Improvement Scotland Think Frailty Tool: A Preliminary Psychometric Evaluation
Sep 22, 2025, 16:24 PM -
Comparative Performance of the EQ-5D-5L and PROMIS-10 in the Elderly: Data From the EQ-DAPHNIE Project in Five Countries
Sep 22, 2025, 16:24 PM -
Predicting Treatment Effect on the Loss of Ability to Rise From Floor in Duchenne Muscular Dystrophy Using Individual Trajectories: An Application of Joint Modeling in FOR-DMD
Sep 22, 2025, 16:24 PM -
Assessment of Mortality and COPD Exacerbations in GOLD E COPD Patients in the Netherlands
Sep 22, 2025, 16:24 PM -
Survival Time-Adjusted Indirect Comparisons: A New Methodology for Comparing Between Phases of Treatment in Early Cancer
Sep 22, 2025, 16:24 PM -
Optimizing the Use of Excess Hazard Models in Survival Analysis: Considering Disease Severity and Follow-up Maturity
Sep 22, 2025, 16:24 PM -
A Framework for Accelerating Clinical Development With Real-World External Control Arms (ECA) in Phase 2 Trials
Sep 22, 2025, 16:24 PM -
Real-World Evidence of Healthcare Resource Utilization in Cystic Fibrosis (CF) Patients Treated With Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in France Using Long-term Data From the SNDS Database Linked to the French CF Registry: Findings From...
Sep 22, 2025, 16:24 PM
